Stock analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research report issued on Thursday. The firm set a “hold” rating on the stock.
Milestone Scientific Stock Up 7.3 %
NYSE:MLSS opened at $1.00 on Thursday. The firm has a market capitalization of $77.08 million, a PE ratio of -9.98 and a beta of 0.88. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.19. The firm has a 50-day moving average price of $0.85 and a 200 day moving average price of $0.73.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). The firm had revenue of $1.85 million during the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%.
Insiders Place Their Bets
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
- Five stocks we like better than Milestone Scientific
- Short Selling: How to Short a Stock
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- The Basics of Support and Resistance
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- 3 Healthcare Dividend Stocks to Buy
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.